Etiometry Recognized as Quarterfinalist for the 2025 Digital Health Hub Foundation: Digital Health Awards
News and Press Releases
September 16, 2025- BOSTON- Etiometry is thrilled to announce its selection as a quarterfinalist for the prestigious 2025 Digital Health Hub Foundation: Digital Health Awards. Etiometry was chosen as a quarterfinalist for the Best In Class – AI for Patient Care.
This recognition highlights the company’s dedication to improving patient outcomes, enhancing clinical efficiency with deep physiologic insights, and lowering the cost of care through AI-powered insights and advanced analytics. The Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. As a quarterfinalist, Etiometry stands out for its commitment to transforming complex clinical data into actionable insights that empower care teams, standardize workflows, and ultimately elevate the quality of care for critically ill patients.
“We are honored to be named a quarterfinalist in the 2025 Digital Health Awards,” said Shane Cooke, President & CEO of Etiometry. “This recognition reflects our commitment to providing clinical insights that revolutionize patient care and support more informed decisions. It’s inspiring to see digital health innovations like ours gaining momentum and driving meaningful improvements in the delivery of critical care.”
Out of a substantial pool of over 1,800 submissions, only the most promising 16 quarterfinalists per category, per track have advanced to this stage.
“The 2025 Awards have once again raised the bar, drawing an unprecedented range of global submissions that highlight the rapid evolution of AI and impact of digital health. Congratulations to all of our quarterfinalists for pushing the boundaries of what’s possible and driving meaningful change in healthcare,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation.
Finalists will be announced October 4, 2025.
###
About Digital Health Hub Foundation:
Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.
About Etiometry
Founded in 2010, Etiometry is a leader in clinical decision-support software designed to help clinicians in intensive care units make data-driven, proactive decisions. By leveraging advanced analytics and AI-powered insights, the company empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times.
Etiometry has received ten FDA clearances and is trusted by leading healthcare institutions worldwide, including top-ranked academic medical centers and pediatric hospitals. The company is committed to advancing patient safety, improving clinical efficiency, and lowering the cost of care through smarter data utilization.
To learn more, visit www.etiometry.com.
Media Contact
Hyedi Nelson
Bellmont Partners
Hyedi@bellmontpartners.com
651-757-7054
Related
New Study Validates Non-Invasive Prediction of Carbon Dioxide Retention in Neonates Using Etiometry’s Clinical Intelligence Platform
September 9, 2025 – BOSTON – A newly published study in the Journal of Perinatology has validated a breakthrough predictive tool, IVCO2, that accurately estimates the risk of carbon dioxide (CO2) retention in neonates using Etiometry’s Clinical Intelligence Platform. Unlike traditional monitoring methods that rely on skin sensors and can compromise the skin integrity of […]
Why Measuring Key Clinical Markers Matters in Cardiogenic Shock
Cardiogenic shock (CS) remains a critical issue in hospitals nationwide. Despite advances in interventional cardiology, CS is a high-mortality condition, with mortality ranges from 30% to 40%, and 1-year mortality approaches or exceeds 50%. One of the main challenges is the rapid progression of CS severity. Historically, staging using the Society for Cardiovascular Angiography and […]
Why Conventional EHR Systems Are Insufficient for Shock Detection
Cardiogenic shock (CS) remains a critical and life-threatening condition, characterized by a rapid decline in cardiac function and multi-organ dysfunction, often leading to high mortality rates. Despite advancements in critical care, its intricate and rapidly evolving nature presents a formidable clinical challenge. Early identification and prompt intervention are paramount for improved patient outcomes. However, the […]